Sfoglia per Autore
Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis
2012 Lisotti A; Azzaroli F; Buonfiglioli F; Cecinato P; Montagnani M; Simoni P; Calvanese C; Arena R; Grande G; Belvisi S; Porro A; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G
Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis.
2012 Lisotti A, Azzaroli F, Buonfiglioli F Cecinato P, Montagnani M, Patrizia S, Calvanese C, Arena R, Grande G, Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G
Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis
2013 Lisotti A, Azzaroli F, Buonfiglioli F, Cecinato P, Montagnani M, Arena R, Calvanese C, Simoni P, Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G
Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma
2014 Lisotti, Andrea; Azzaroli, Francesco; Montagnani, Marco; Porro, Alberto; Mazzella, Giuseppe
The future of dual therapy for hepatitis C virus
2014 Francesco Azzaroli;Marco Montagnani;Alberto Porro;Domenico Fiorillo;Giuseppe Mazzella
Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis.
2014 Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M; Cecinato P; Calvanese, C; Patrizia, S; Porro, A; Fiorillo, D; Cucchetti A; Colecchia A, Golfieri R, Festi D, Mazzella G.
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens
2017 Ravaioli, F.; Marasco, G.; Reggiani, M.L.B.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti, S.; Colecchia, A.; Festi, D.
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens
2017 Ravaioli, F.; Marasco, G.; Bacchi Reggiani, M.L.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti, S.; Colecchia, A.; Festi, D.
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older
2017 Conti, F.; Brillanti, S.; Buonfiglioli, F.; Vukotic, R.; Morelli, M.C.; Lalanne, C.; Massari, M.; Foschi, F.G.; Bernabucci, V.; Serio, I.; Prati, G.M.; Negri, E.; Badia, L.; Caraceni, P.; Muratori, P.; Vitale, G.; Porro, A.; Morotti, M.; Mazzella, G.; Andreone, P.
IL28 polymorphism and HCC after DAAs for chronic hepatitis C
2018 Simili, A.; Mazzella, G.; Ravaioli, F.; Davide, F.; Bacchi-Reggiani, M.L.; Porro, A.; Bazzoli, F.; Azzaroli, F.
P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C
2018 Simili, A.; Mazzella, G.; Ravaioli, F.; Festi, D.; Reggiani, M.L. Bacchi; Porro, A.; Bazzoli, F.; Azzaroli, F.
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients
2019 Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti, S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Indocyanine Green Clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis | Lisotti A; Azzaroli F; Buonfiglioli F; Cecinato P; Montagnani M; Simoni P; Calvanese C; Arena R; ...Grande G; Belvisi S; Porro A; Cucchetti A; Colecchia A; Festi D; Golfieri R; Mazzella G | 2012-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Indocyanine green clearance (ICG) as a predictor of clinical decompensation and mortality in patients with compensated liver cirrhosis. | Lisotti A, Azzaroli F, Buonfiglioli F Cecinato P, Montagnani M, Patrizia S, Calvanese C, Arena R..., Grande G, Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G | 2012-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Indocyanine green clearance (ICG) as a predictor of 2-years clinical decompensation and mortality in patients with compensated liver cirrhosis | Lisotti A, Azzaroli F, Buonfiglioli F, Cecinato P, Montagnani M, Arena R, Calvanese C, Simoni P, ...Belvisi S, Porro A, Cucchetti A, Colecchia A, Festi D, Golfieri R, Mazzella G | 2013-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Correlation between Indocyanine green retention test and esophageal varices among patients with hepatocellular carcinoma | Lisotti, Andrea; Azzaroli, Francesco; Montagnani, Marco; Porro, Alberto; Mazzella, Giuseppe | 2014-01-01 | JOURNAL OF GASTROENTEROLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| The future of dual therapy for hepatitis C virus | Francesco Azzaroli;Marco Montagnani;Alberto Porro;Domenico Fiorillo;Giuseppe Mazzella | 2014-01-01 | FUTURE VIROLOGY | - | 1.01 Articolo in rivista | - |
| Indocyanine Green 15-min Retention test (ICG-r15) as a predictor of clinical decompensation in patients with compensated liver cirrhosis. | Lisotti A, Azzaroli F, Buonfiglioli F, Montagnani M; Cecinato P; Calvanese, C; Patrizia, S; Porro..., A; Fiorillo, D; Cucchetti A; Colecchia A, Golfieri R, Festi D, Mazzella G. | 2014-01-01 | HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens | Ravaioli, F.; Marasco, G.; Reggiani, M.L.B.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Brillanti..., S.; Colecchia, A.; Festi, D. | 2017-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens | Ravaioli, F.; Marasco, G.; Bacchi Reggiani, M.L.; Mazzella, G.; Buonfiglioli, F.; Porro, A.; Bril...lanti, S.; Colecchia, A.; Festi, D. | 2017-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older | Conti, F.; Brillanti, S.; Buonfiglioli, F.; Vukotic, R.; Morelli, M.C.; Lalanne, C.; Massari, M.;... Foschi, F.G.; Bernabucci, V.; Serio, I.; Prati, G.M.; Negri, E.; Badia, L.; Caraceni, P.; Muratori, P.; Vitale, G.; Porro, A.; Morotti, M.; Mazzella, G.; Andreone, P. | 2017-01-01 | JOURNAL OF VIRAL HEPATITIS | - | 1.01 Articolo in rivista | - |
| IL28 polymorphism and HCC after DAAs for chronic hepatitis C | Simili, A.; Mazzella, G.; Ravaioli, F.; Davide, F.; Bacchi-Reggiani, M.L.; Porro, A.; Bazzoli, F....; Azzaroli, F. | 2018-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| P.09.6 IL28 POLYMORPHISM AND HCC DEVELOPMENT AFTER DAAS FOR CHRONIC HEPATITIS C | Simili, A.; Mazzella, G.; Ravaioli, F.; Festi, D.; Reggiani, M.L. Bacchi; Porro, A.; Bazzoli, F.;... Azzaroli, F. | 2018-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.06 Abstract in rivista | - |
| Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients | Ravaioli, F.; Dajti, E.; Simoni, P.; Porro, A.; Marasco, G.; Alemanni, L.V.; Tamè, M.; Brillanti,... S.; Colecchia, A.; Montagnani, M.; Festi, D.; Mazzella, G.; Azzaroli, F. | 2019-01-01 | DIGESTIVE AND LIVER DISEASE | - | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile